# AGENEBIO, INC.: Preclinical and early clinical development of a GABA-A a5 PAM

**Lab Budget Score:** 40/100

| Field | Value |
|---|---|
| Organization | AGENEBIO, INC. |
| Location | Baltimore, MD |
| Project | Preclinical and early clinical development of a GABA-A a5 PAM |
| Project number | 3U01AG074950-04S1 |
| Mechanism | U01 |
| Institute | National Institute on Aging |
| Award | $203,500 |
| Awarded | 2026-08-27 |
| Project period | 2022-09-01 to 2027-08-31 |
| UEI | YZWJGZMT3MN5 |

## Why this score
- Award of $203,500.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11529495). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.